R-(-)-BPAP: Evidence Card. A Literature, Patent and Registry Dossier
R-(-)-BPAP dossier: 61 records, 93.5% of primary work by the developers, one 10-patient EudraCT trial, and the rat lifespan cohort recalculated.
-
-
ACD856: The Evidence Card. A Trk Modulator Whose Structure Has Never Been Disclosed
ACD856 evidence card: every PubMed record and trial checked, the stopped ponazuril study, the undisclosed structure vendors sell, and 18 forum claims tested.
-
GB-115 (Ranquilon): Evidence Card. A Regulatory and Literature Dossier
GB-115 / Ranquilon dossier: 52 sources in English and Russian, 90% co-authored by one lineage, 7 human studies, weak binding data in one abstract. v1.4.
-
TAK-653 (Osavampator): The Evidence Dossier. A Forum Nootropic in a Phase 3 Depression Programme
TAK-653 (osavampator) evidence dossier: 13 PubMed records and 9 trials classified, 19 forum claims checked, and what phase 2 SAVITRI reported, source by source.
-
HBT1: Takeda’s AMPA Receptor Potentiator, One Paper and Everything Else That Is Known
HBT1 is a Takeda AMPA receptor potentiator known from one 2018 in vitro paper: identity, binding, the 5YBF structure, zero human trials, and what is missing.
-
Adamax: The Evidence Card. A Peptide Sold Without a Paper
Adamax evidence card: 0 papers, 0 trials and no primary source for its structure. Three vendor descriptions, three molecules; 16 claims checked against sources.
-
What is Adalank? A stabilised Selank analogue with no literature of its own
Adalank appears on vendor listings as a “stabilised” or “second-generation” version of Selank, usually alongside the same bullet points that circulate about Selank itself. The claim is specific enough to be testable: a modified peptide, more resistant to breakdown, otherwise equivalent. So we tested it the way we test any compound before it goes near…
-
What Is Noopept? The Proline-Containing Dipeptide Nootropic
Noopept (omberacetam, GVS-111): a proline-containing dipeptide designed as a piracetam analogue. Its chemistry, the proposed prodrug metabolite, and an honest read of the single-lab evidence.
-
What Is Bromantane (Ladasten)? The Russian Actoprotector, Examined
Bromantane (Ladasten) is a Russian actoprotector that raises dopamine synthesis enzymes rather than blocking reuptake. What the rodent and clinical literature actually shows.
-
P21: The Neurogenesis Peptide That Has Never Met a Human
A CNTF-derived fragment rebuilt to cross the blood-brain barrier and switch on BDNF. The rodent data are genuinely striking. The translational record of everything that came before it is not.
